<?xml version="1.0" encoding="UTF-8" ?>
<rss version="2.0" xmlns:atom="http://www.w3.org/2005/Atom">
  <channel>
    <title>Cayman Journal - Crescent Biopharma Inc (CBIO)</title>
    <description>Latest news, press releases, and SEC filings for Crescent Biopharma Inc (CBIO)</description>
    <link>https://caymanjournal.com/stock/CBIO</link>
    <language>en-us</language>
    
    <copyright>Copyright 2026, Cayman Journal</copyright>
    <managingEditor>editorial@caymanjournal.com (Editorial Team)</managingEditor>
    <webMaster>webmaster@caymanjournal.com (Web Master)</webMaster>
    <lastBuildDate>Tue, 28 Apr 2026 00:10:31 GMT</lastBuildDate>
    <ttl>60</ttl>
    <atom:link href="https://caymanjournal.com/stock/CBIO/feed.xml" rel="self" type="application/rss+xml" />
    <image>
      <url>https://caymanjournal.com/logo.png</url>
      <title>Cayman Journal</title>
      <link>https://caymanjournal.com</link>
      <width>144</width>
      <height>144</height>
    </image>

    <item>
      <title>DEF 14A — CRESCENT BIOPHARMA, INC.</title>
      <description># 🧾 What This Document Is 📜
This is a Proxy Statement (Schedule 14A), which is a critical legal filing used by companies to gather votes from their shareholders. It outlines the major business and governance decisions that shareholders are expected to vote on at the company’s Annual General Meetin</description>
      <link>https://caymanjournal.com/stock/CBIO/sec-filing/0001628280-26-026282</link>
      <guid isPermaLink="true">https://caymanjournal.com/stock/CBIO/sec-filing/0001628280-26-026282</guid>
      <pubDate>Tue, 21 Apr 2026 00:00:00 GMT</pubDate>
      
      <category>SEC Filing</category>
      
    </item>
  </channel>
</rss>